These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 24857631

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer's disease.
    Yahiaoui S, Hamidouche K, Ballandonne C, Davis A, de Oliveira Santos JS, Freret T, Boulouard M, Rochais C, Dallemagne P.
    Eur J Med Chem; 2016 Oct 04; 121():283-293. PubMed ID: 27266998
    [Abstract] [Full Text] [Related]

  • 4. Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer's disease: the design of donecopride.
    Rochais C, Lecoutey C, Gaven F, Giannoni P, Hamidouche K, Hedou D, Dubost E, Genest D, Yahiaoui S, Freret T, Bouet V, Dauphin F, Sopkova de Oliveira Santos J, Ballandonne C, Corvaisier S, Malzert-Fréon A, Legay R, Boulouard M, Claeysen S, Dallemagne P.
    J Med Chem; 2015 Apr 09; 58(7):3172-87. PubMed ID: 25793650
    [Abstract] [Full Text] [Related]

  • 5. New developments around histamine H(3) receptor antagonists/inverse agonists: a patent review (2010 - present).
    Łażewska D, Kieć-Kononowicz K.
    Expert Opin Ther Pat; 2014 Jan 09; 24(1):89-111. PubMed ID: 24131059
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis and structure-activity relationship studies in serotonin 5-HT4 receptor ligands based on a benzo[de][2,6]naphthridine scaffold.
    Castriconi F, Paolino M, Giuliani G, Anzini M, Campiani G, Mennuni L, Sabatini C, Lanza M, Caselli G, De Rienzo F, Menziani MC, Sbraccia M, Molinari P, Costa T, Cappelli A.
    Eur J Med Chem; 2014 Jul 23; 82():36-46. PubMed ID: 24871995
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. New lead elements for histamine H3 receptor ligands in the pyrrolo[2,3-d]pyrimidine class.
    Espinosa-Bustos C, Frank A, Arancibia-Opazo S, Salas CO, Fierro A, Stark H.
    Bioorg Med Chem Lett; 2018 Sep 15; 28(17):2890-2893. PubMed ID: 30025902
    [Abstract] [Full Text] [Related]

  • 11. Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017).
    Łażewska D, Kieć-Kononowicz K.
    Expert Opin Ther Pat; 2018 Mar 15; 28(3):175-196. PubMed ID: 29334795
    [Abstract] [Full Text] [Related]

  • 12. 4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists.
    Wijtmans M, Celanire S, Snip E, Gillard MR, Gelens E, Collart PP, Venhuis BJ, Christophe B, Hulscher S, van der Goot H, Lebon F, Timmerman H, Bakker RA, Lallemand BI, Leurs R, Talaga PE, de Esch IJ.
    J Med Chem; 2008 May 22; 51(10):2944-53. PubMed ID: 18433114
    [Abstract] [Full Text] [Related]

  • 13. Effects of histamine H3 receptor ligands on the rewarding, stimulant and motor-impairing effects of ethanol in DBA/2J mice.
    Nuutinen S, Vanhanen J, Pigni MC, Panula P.
    Neuropharmacology; 2011 Jun 22; 60(7-8):1193-9. PubMed ID: 21044640
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Structural modifications in the distal, regulatory region of histamine H3 receptor antagonists leading to the identification of a potent anti-obesity agent.
    Szczepańska K, Pockes S, Podlewska S, Höring C, Mika K, Latacz G, Bednarski M, Siwek A, Karcz T, Nagl M, Bresinsky M, Mönnich D, Seibel U, Kuder KJ, Kotańska M, Stark H, Elz S, Kieć-Kononowicz K.
    Eur J Med Chem; 2021 Mar 05; 213():113041. PubMed ID: 33261900
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Identification of a HEK-293 cell line containing stably-transfected H3R gene and screening for novel non-imidazole histamine H3 receptor antagonists].
    He P, Tan L, Hu W, Dai H, Hu Y, Chen Z.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 May 05; 42(3):276-82. PubMed ID: 23801615
    [Abstract] [Full Text] [Related]

  • 19. Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.
    Gbahou F, Vincent L, Humbert-Claude M, Tardivel-Lacombe J, Chabret C, Arrang JM.
    Br J Pharmacol; 2006 Apr 05; 147(7):744-54. PubMed ID: 16432504
    [Abstract] [Full Text] [Related]

  • 20. Novel and highly potent histamine H3 receptor ligands. Part 3: an alcohol function to improve the pharmacokinetic profile.
    Labeeuw O, Levoin N, Poupardin-Olivier O, Calmels T, Ligneau X, Berrebi-Bertrand I, Robert P, Lecomte JM, Schwartz JC, Capet M.
    Bioorg Med Chem Lett; 2013 May 01; 23(9):2548-54. PubMed ID: 23535326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.